PYRIDOXINE HYDROCHLORIDE - Generic Drug Details

What are the generic sources for pyridoxine hydrochloride and what is the scope of patent protection?

Pyridoxine hydrochloride is the generic ingredient in two branded drugs marketed by Lilly, Bel Mar, Dell Labs, Dr Reddys, Elkins Sinn, Epic Pharma Llc, Fresenius Kabi Usa, Luitpold, Mylan Institutional, and Watson Labs, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for pyridoxine hydrochloride. Two suppliers are listed for this compound.

Summary for PYRIDOXINE HYDROCHLORIDE

US Patents:	0
Tradenames:	2
Applicants:	10
NDAs:	11
Drug Master File Entries:	4
Finished Product Suppliers / Packagers:	2
Raw Ingredient (Bulk) Api Vendors:	1
Clinical Trials:	89
Patent Applications:	7,003
What excipients (inactive ingredients) are in PYRIDOXINE HYDROCHLORIDE?	PYRIDOXINE HYDROCHLORIDE excipients list
DailyMed Link:	PYRIDOXINE HYDROCHLORIDE at DailyMed

Recent Clinical Trials for PYRIDOXINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Bahria University	NA
Innovative Medicines Initiative	PHASE2
TASK Applied Science	PHASE2

See all PYRIDOXINE HYDROCHLORIDE clinical trials

Pharmacology for PYRIDOXINE HYDROCHLORIDE

Ingredient-type	Analogs/Derivatives Vitamin B 6
Drug Class	Vitamin B6 Analog

Medical Subject Heading (MeSH) Categories for PYRIDOXINE HYDROCHLORIDE

Vitamin B Complex

US Patents and Regulatory Information for PYRIDOXINE HYDROCHLORIDE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Fresenius Kabi Usa	PYRIDOXINE HYDROCHLORIDE	pyridoxine hydrochloride	INJECTABLE;INJECTION	080618-001	Approved Prior to Jan 1, 1982		RX	Yes	Yes
Lilly	HEXA-BETALIN	pyridoxine hydrochloride	INJECTABLE;INJECTION	080854-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Luitpold	PYRIDOXINE HYDROCHLORIDE	pyridoxine hydrochloride	INJECTABLE;INJECTION	080669-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Mylan Institutional	PYRIDOXINE HYDROCHLORIDE	pyridoxine hydrochloride	INJECTABLE;INJECTION	204879-001	Jul 14, 2016		DISCN	No	No
Dell Labs	PYRIDOXINE HYDROCHLORIDE	pyridoxine hydrochloride	INJECTABLE;INJECTION	083772-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Elkins Sinn	PYRIDOXINE HYDROCHLORIDE	pyridoxine hydrochloride	INJECTABLE;INJECTION	080581-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Dr Reddys	PYRIDOXINE HYDROCHLORIDE	pyridoxine hydrochloride	INJECTABLE;INJECTION	080572-001	Approved Prior to Jan 1, 1982		DISCN	No	No

Market Dynamics and Financial Trajectory for Pyridoxine Hydrochloride

Last updated: December 28, 2025

Executive Summary

Pyridoxine Hydrochloride (Vitamin B6) is a vital nutrient used extensively within pharmaceuticals, dietary supplements, and fortification markets globally. Its broad application spectrum, coupled with rising health consciousness and increasing prevalence of conditions such as anemia and neurological disorders, sustains robust demand growth. This analysis explores the current market landscape, key drivers, challenges, opportunities, and financial trajectories shaping the future of Pyridoxine Hydrochloride. It also provides insights into competitive dynamics, regulatory frameworks, and strategic considerations vital for stakeholders.

---

1. Introduction: What Is Pyridoxine Hydrochloride?

Pyridoxine Hydrochloride is a water-soluble vitamin (Vitamin B6) critical for amino acid metabolism, neurotransmitter synthesis, hemoglobin production, and immune function. Recognized as an essential nutrient, it is dispensed as a standalone supplement and incorporated into multiple multivitamin formulations.

Chemical Profile

Parameter	Details
Chemical Name	Pyridoxine Hydrochloride
CAS Number	51-83-2
Molecular Formula	C8H11NO3·HCl
Molecular Weight	205.65 g/mol

Market Application Sectors:

• Pharmaceuticals (therapeutic formulations)
• Dietary Supplements (OTC products)
• Food Fortification
• Animal Nutrition

---

2. Market Drivers: What Is Propelling Growth?

a. Rising Prevalence of Deficiencies and Health Conditions

• Vitamin B6 Deficiency: Increasing global prevalence due to malnutrition, particularly in developing nations.
• Neurological Disorders: Growing awareness and diagnosis of conditions like peripheral neuropathy and depression.
• Anemia and Immune Support: Increased supplementation to support immune functions, especially post-pandemic.

b. Expanding Dietary Supplement Market

• The global dietary supplements market is projected to reach USD 278.02 billion by 2024 at a CAGR of 7.4% (2020-2024) [1].
• Vitamin B6, including Pyridoxine Hydrochloride, constitutes a significant share due to demand for immunity boosting and general health.

c. Pharmaceuticals and Fortification Trends

• The incidence of chronic illnesses and metabolic disorders accelerates demand for pharmaceutical-grade Pyridoxine Hydrochloride.
• Food fortification initiatives in countries like India and Nigeria enhance micronutrient intake, expanding market reach.

d. Regulatory and Policy Environment

• WHO recommends adequate intake levels, promoting supplementation.
• Regulatory classification (self-medication vs. prescription) varies by region, impacting market entry strategies.

---

3. Market Size and Forecast

a. Current Market Valuation

Region	Estimated Market Size (USD Billion)	Key Trends
North America	~$0.75 billion (2022)	High supplement consumption, mature pharma
Europe	~$0.50 billion	Strong food fortification policies
Asia-Pacific	~$1.0 billion	Rapid urbanization, growing supplement use
Rest of World	~$0.25 billion	Emerging markets, rising awareness

Total Global Market (2022): Approximately USD 2.5 billion.

b. Forecasts (2023-2028)

Year	Predicted Market Size (USD Billion)	CAGR
2023	~$2.75 billion	10%
2024	~$3.02 billion
2025	~$3.31 billion	10%
2026	~$3.64 billion
2027	~$4.00 billion
2028	~$4.40 billion	10%

Source: MarketResearchFuture, 2022 [2]

---

4. Competitive Landscape

a. Major Market Players

Company	Market Share (%)	Production Capacity	Strategic Moves
DSM (Netherlands)	20%	>10,000 MT/year	Vertical integration, R&D investments
BASF (Germany)	15%	>8,000 MT/year	Capacity expansion, mergers
Zhejiang NHU Co., Ltd.	12%	>5,000 MT/year	Regional expansion
others	53%	Varies	Diversification, M&A

Major players leverage integrated supply chains and diversified product portfolios.

b. Production & Supply Flows

Aspect	Details
Raw Materials	Pyridoxine synthesized via chemical or microbial routes
Manufacturing Countries	China (~60%), India, Europe, North America
Pricing Trends	Declining due to oversupply; recent stabilization
Supply Chain Risks	Raw material scarcity, geopolitical tensions

---

5. Market Challenges and Barriers

Challenge	Impact
Regulatory Hurdles	Variability impacts time-to-market and costs
Price Volatility	Market oversupply leads to price fluctuations
Raw Material Availability	Dependent on chemical feedstocks or microbial processes
Competition from Generics	Market saturation limits profit margins

---

6. Future Opportunities

a. Innovation and Product Differentiation

• Development of sustained-release and bioavailable formulations.
• Integration into functional foods targeting specific demographics.

b. Emerging Markets

• Significant growth potential in regions with rising health awareness.
• Government initiatives promoting micronutrient fortification.

c. Strategic Alliances

• Partnerships with pharma and nutraceutical companies.
• Vertical integration to control raw material sourcing and distribution.

---

7. Regulatory and Policy Framework

Region	Regulatory Authority	Key Policies	Implication for Market
USA	FDA	GRAS status, supplement standards	Easier market access
EU	EMA, EFSA	Novel food regulations, fortification policies	Stringent; compliance needed
China	CFDA	Food additive regulations, GMP standards	Growing demand; strict oversight
India	FSSAI	Fortification mandates, supplement regulations	Opportunities in fortification

---

8. Comparing Pyridoxine Hydrochloride to Other Forms of Vitamin B6

Feature	Pyridoxine Hydrochloride	Pyridoxal-5-phosphate (P5P)	Pyridoxamine
Bioavailability	High	Higher	Moderate
Stability	Good	Excellent	Moderate
Cost	Lower	Higher	Similar
Regulatory Status	Widely accepted in supplements	Generally recognized as active form	Less common in market

---

Key Takeaways

• Market Growth: The Pyridoxine Hydrochloride market is expected to grow at a CAGR of approximately 10% through 2028, driven by supplement demand and food fortification initiatives.
• Major Drivers: Rising malnutrition, chronic disease prevalence, and governmental policies favoring micronutrient fortification.
• Competitive Landscape: Dominated by DSM and BASF, with a fragmented but expanding supplier base, primarily in China and India.
• Challenges: Regulatory complexities, raw material supply constraints, and price competition.
• Opportunities: Innovation in delivery forms, strategic alliances, expanding into emerging markets, and leveraging regulatory support for fortification projects.
• Regulatory Impact: Variations necessitate tailored compliance strategies; global harmonization efforts could streamline market entry.

---

FAQs

1. What factors influence Pyridoxine Hydrochloride prices?
Prices are affected by raw material costs, supply-demand imbalances, regulatory policies, and production efficiencies. Oversupply has historically driven prices down, but recent stabilization reflects healthier market dynamics.

2. Which regions exhibit the highest growth potential?
Asia-Pacific and Africa demonstrate significant growth due to expanding supplement markets and food fortification policies, coupled with rising health awareness.

3. How does regulatory variation affect market entry?
Differing standards for supplementation, food fortification, and pharmaceuticals impact approval timelines and costs, requiring region-specific strategies.

4. What are the key applications of Pyridoxine Hydrochloride?
Major applications include dietary supplements, prescription drugs for deficiency conditions, and as a functional ingredient in fortified foods.

5. How is innovation impacting the Pyridoxine Hydrochloride market?
Advancements in bioavailability, stability, and delivery mechanisms (e.g., sustained-release formulations) are creating new opportunities for manufacturer differentiation and expanded indications.

---

References

[1] Grand View Research, “Dietary Supplements Market Size & Trends,” 2020.
[2] MarketResearchFuture, “Vitamin B6 Market Analysis & Forecast,” 2022.